Using Single-Photon Emission Computerized Tomography on Patients With Positive Quantitative Electroencephalogram to Evaluate Chronic Mild Traumatic Brain Injury With Persistent Symptoms.

concussion neuropsychiatric symptoms post-concussion syndrome (PCS) quantitative EEG (qEEG) single photon emission computed tomography (SPECT) traumatic brain injury (TBI)

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 04 05 2021
accepted: 24 02 2022
entrez: 9 5 2022
pubmed: 10 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Following mild traumatic brain injury (mTBI), also known as concussion, many patients with chronic symptoms (>3 months post injury) receive conventional imaging such as computed tomography (CT) or magnetic resonance imaging (MRI). However, these modalities often do not show changes after mTBI. We studied the benefit of triaging patients with ongoing symptoms >3 months post injury by quantitative electroencephalography (qEEG) and then completing a brain single positron emission computed tomography (SPECT) to aid in diagnosis and early detection of brain changes. We conducted a retrospective case review of 30 outpatients with mTBI. The patients were assessed by a neurologist, consented, and received a qEEG, and if the qEEG was positive, they consented and received a brain SPECT scan. The cases and diagnostic tools were collectively reviewed by a multidisciplinary group of physicians in biweekly team meetings including neurology, nuclear medicine, psychiatry, neuropsychiatry, general practice psychotherapy, neuro-ophthalmology, and chiropractic providers. The team noted the cause of injury, post injury symptoms, relevant past medical history, physical examination findings, and diagnoses, and commented on patients' SPECT scans. We then analyzed the SPECT scans quantitatively using the 3D-SSP software. All the patients had cerebral perfusion abnormalities demonstrated by SPECT that were mostly undetectable by conventional imaging (CT/MRI). Perfusion changes were localized primarily in the cerebral cortex, basal ganglia, and cingulate cortex, and correlated with the patients' symptoms and examination findings. Qualitative and quantitative analyses yielded similar results. Most commonly, the patients experienced persistent headache, memory loss, concentration difficulties, depression, and cognitive impairment post mTBI. Because of their symptoms, most of the patients were unable to return to their previous employment and activity level. Our findings outline the physical basis of neurological and psychiatric symptoms experienced by patients with mTBI. Increased detection of mTBI can lead to development of improved targeted treatments for mTBI and its various sequelae.

Sections du résumé

Background UNASSIGNED
Following mild traumatic brain injury (mTBI), also known as concussion, many patients with chronic symptoms (>3 months post injury) receive conventional imaging such as computed tomography (CT) or magnetic resonance imaging (MRI). However, these modalities often do not show changes after mTBI. We studied the benefit of triaging patients with ongoing symptoms >3 months post injury by quantitative electroencephalography (qEEG) and then completing a brain single positron emission computed tomography (SPECT) to aid in diagnosis and early detection of brain changes.
Methods UNASSIGNED
We conducted a retrospective case review of 30 outpatients with mTBI. The patients were assessed by a neurologist, consented, and received a qEEG, and if the qEEG was positive, they consented and received a brain SPECT scan. The cases and diagnostic tools were collectively reviewed by a multidisciplinary group of physicians in biweekly team meetings including neurology, nuclear medicine, psychiatry, neuropsychiatry, general practice psychotherapy, neuro-ophthalmology, and chiropractic providers. The team noted the cause of injury, post injury symptoms, relevant past medical history, physical examination findings, and diagnoses, and commented on patients' SPECT scans. We then analyzed the SPECT scans quantitatively using the 3D-SSP software.
Results UNASSIGNED
All the patients had cerebral perfusion abnormalities demonstrated by SPECT that were mostly undetectable by conventional imaging (CT/MRI). Perfusion changes were localized primarily in the cerebral cortex, basal ganglia, and cingulate cortex, and correlated with the patients' symptoms and examination findings. Qualitative and quantitative analyses yielded similar results. Most commonly, the patients experienced persistent headache, memory loss, concentration difficulties, depression, and cognitive impairment post mTBI. Because of their symptoms, most of the patients were unable to return to their previous employment and activity level.
Conclusion UNASSIGNED
Our findings outline the physical basis of neurological and psychiatric symptoms experienced by patients with mTBI. Increased detection of mTBI can lead to development of improved targeted treatments for mTBI and its various sequelae.

Identifiants

pubmed: 35528740
doi: 10.3389/fneur.2022.704844
pmc: PMC9074759
doi:

Types de publication

Journal Article

Langues

eng

Pagination

704844

Informations de copyright

Copyright © 2022 Gosset, Wagman, Pavel, Cohen, Tarzwell, Bruin, Siow, Numerow, Uszler, Rossiter-Thornton, McLean, Lierop, Waisman, Brown, Mansouri, Basile, Chaudhary and Mehdiratta.

Déclaration de conflit d'intérêts

MM has an interest in iScope Concussion and Pain Clinics, which uses qEEG and SPECT as part of the clinic. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA Netw Open. 2021 Feb 1;4(2):e2037349
pubmed: 33587137
Brain Inj. 2015;29(6):688-700
pubmed: 25871303
PLoS One. 2015 Jul 01;10(7):e0129659
pubmed: 26132293
J Rehabil Med. 2004 Feb;(43 Suppl):76-83
pubmed: 15083872
Am J Emerg Med. 2018 Jan;36(1):142-143
pubmed: 28709713
PLoS One. 2014 Mar 19;9(3):e91088
pubmed: 24646878
Psychiatry Res. 2015 Jan 30;231(1):15-24
pubmed: 25466236
J Clin Neurophysiol. 2019 Jul;36(4):298-305
pubmed: 31094883
J Nucl Med. 2000 Sep;41(9):1456-64
pubmed: 10994723
J Nucl Med. 1994 Sep;35(9):1528-37
pubmed: 8071705
Brain Imaging Behav. 2012 Jun;6(2):137-92
pubmed: 22438191
J Head Trauma Rehabil. 2018 Jan/Feb;33(1):1-6
pubmed: 28520677
AJNR Am J Neuroradiol. 1994 Sep;15(8):1583-9
pubmed: 7985582
IEEE Trans Neural Syst Rehabil Eng. 2019 Jul;27(7):1492-1501
pubmed: 31199262
Continuum (Minneap Minn). 2014 Dec;20(6 Sports Neurology):1552-69
pubmed: 25470160
JAMA Neurol. 2019 Sep 01;76(9):1049-1059
pubmed: 31157856
Brain Imaging Behav. 2012 Jun;6(2):108-36
pubmed: 22434552
Indian J Nucl Med. 2014 Oct;29(4):210-21
pubmed: 25400359

Auteurs

Alexi Gosset (A)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Hayley Wagman (H)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Dan Pavel (D)

University of Illinois Medical Center, Chicago, IL, United States.

Philip Frank Cohen (PF)

Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Robert Tarzwell (R)

Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Simon de Bruin (S)

Good Lion Imaging, Columbia, MD, United States.

Yin Hui Siow (YH)

Southlake Regional Health Centre, Newmarket, ON, Canada.

Leonard Numerow (L)

Faculty of Medicine, University of Calgary, Calgary, AB, Canada.

John Uszler (J)

Faculty of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

John F Rossiter-Thornton (JF)

Rossiter-Thornton Associates, Toronto, ON, Canada.

Mary McLean (M)

Private Practice, Toronto, ON, Canada.
The International Society of Applied Neuroimaging (ISAN), Toronto, ON, Canada.

Muriel van Lierop (M)

Private Practice, Toronto, ON, Canada.

Zohar Waisman (Z)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Stephen Brown (S)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Behzad Mansouri (B)

Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.

Vincenzo Santo Basile (VS)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Navjot Chaudhary (N)

University of Illinois Medical Center, Chicago, IL, United States.

Manu Mehdiratta (M)

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Classifications MeSH